PAPER
Synthesis of Isoxazoline N-Oxides
2269
(dd, J = 5.2, 9.6 Hz, CHO of isomer A), 7.18–7.52 (m, 10 H, C6H5
of both isomers).
13C NMR (50 MHz, CDCl3): d = 14. 1 (CH3), 22.5, 22.9, 25.2, 25.7,
27.4, 29.2, 31.5, 32.5, 39.4, 42.0, 55.0 (CH2, CH and 2 CCN), 79.9
(CHO), 117.0 (C=N).
3-Benzyl-2-tert-butyldimethyl-3-fluoro-5-phenylsilyloxyisox-
azolidine (5b¢) (Two Isomers 1:1)
Anal. Calcd for C14H23NO2: C, 70.85; H, 9.77; N, 5.90. Found: C,
70.57; H, 9.68; N, 6.03.
1H NMR (300 MHz, CDCl3): d = 0.28 (s, 3 H, SiCH3), 0.30 (s, 3 H,
SiCH3), 0.33 (s, 6 H, 2 SiCH3), 1.01 (s, 9 H, t-C4H9), 1.04 (s, 9 H, t-
C4H9), 2.05 (ddd, 1 H, J = 5.1, 13.8, 20.6 Hz, CH of isomer A),
2.36–2.75 (m, 2 H, CH2 of isomer B), 2.97 (ddd, 1 H, J = 9.6, 13.8,
37.1 Hz, CH of isomer A), 3.24–3.40 (m, 2 H, CH2Ph of both iso-
mers), 5.34 (dd, J = 7.4, 9.6 Hz, CHO of isomer B), 5.52 (dd,
J = 5.2, 9.6 Hz, CHO of isomer A), 7.16–7.55 (m, 10 H, C6H5 of
both isomers).
3-Hexyl-6,7-benzo-1-oxa-2-azabicyclo[3.3.04,8]oct-2,3-ene
N-Oxide (2h)
Chromatography: hexanes–EtOAc (10:1 to 1:1); Rf 0.56 (hexanes–
EtOAc, 1:1).
3
1H NMR (300 MHz, CDCl3): d = 0.88 (t, J = 6.6 Hz, 3 H, CH3),
1.18–1.43 (m, 8 H, 4 CH2), 1.45–1.70 (m, 2 H, CH2CH2CN), 2.12–
2.31 (m, 1 H, CHAHBCN), 2.38–2.58 (m, 1 H, CHAHBCN), 3.10 (dd,
Chromatography in toluene–hexanes (from 1:5 to 1:1) [Rf 0.44 (tol-
uene–hexanes 1: 3)] afforded the isomer A.
3
2J = 17.5 Hz, J = 2.2 Hz, 1 H, CHAHBPh), 3.26 (dd, 2J = 17.5 Hz,
3J = 8.1 Hz, 1 H, CHAHBPh), 4.15 (br t, 3J = 8.8 Hz, 1 H, CHCN),
5.90 (d, 3J = 8.8 Hz, 1 H, CHO), 7.19–7.38 (m, 3 H, CHarom), 7.46
(d, 3J = 7.4 Hz, 1 H, CHarom).
Isomer A of 5b¢
1H NMR (200 MHz, CDCl3): d = 0.30 (s, 3 H, SiCH3), 0.35 (s, 3 H,
SiCH3), 1.06 (s, 9 H, t-C4H9), 2.07 (ddd, 1 H, J = 5.1, 13.8, 20.6 Hz,
CH), 2.99 (ddd, 1 H, J = 9.6, 13.8, 37.1 Hz, CH), 3.35–3.46 (m, 2
H, CH2Ph), 5.54 (dd, J = 5.2, 9.6 Hz, CHO), 7.16–7.59 (m, 10 H,
C6H5).
13C NMR (75 MHz, CDCl3): d = 14.0 (CH3), 22.5, 24.9, 25.5, 29.1,
31.4, 35.1 (all CH2), 48.2 (CHCN), 81.5 (CHO), 118.2 (C=N),
125.0, 126.2, 127.7, 129.9 (CHarom), 139.1, 140.7 (Carom).
Anal. Calcd for C16H21NO2: C, 74.10; H, 8.16; N, 5.40. Found: C,
74.20; H, 8.38; N, 5.42.
13C NMR (50 MHz, CDCl3): d = –4.8 (SiCH3), –4.7 (SiCH3), 18.0
(CMe3), 26.0 [C(CH3)3], 40.0 (d, JC,F = 21.0 Hz, CH2) 42.5 (d,
JC,F = 24.3 Hz, CH2), 81.5 (CHO), 118.8 (d, JC,F = 198.6 Hz, CF),
126.9, 127.18, 127.22, 128.0, 128.2, 128.3, 130.0 (d, JC,F = 1.4 Hz)
(all CHarom), 135.3 (Carom), 139.3 (Carom).
3-Hexyl-5-methoxycarbonyl-4-methylisoxazoline N-Oxide (2i)
Chromatography: hexanes to hexanes–EtOAc (1:1); Rf 0.70 (hex-
anes–EtOAc, 1:1).
3
1H NMR (200 MHz, CDCl3): d = 0.86 (t, J = 6.8 Hz, 3 H, CH3),
3-Hexyl-1-oxa-2-azabicyclo[3.3.04,8]oct-2,3-ene N-Oxide (2e)
Chromatography: hexanes to hexanes–EtOAc (1:1); Rf 0.40 (hex-
anes–EtOAc, 1:1).
1.15–1.70 (m, 8 H, 4 CH2), 1.36 (d, 3J = 6.8 Hz, 3 H, CH3), 2.11–
2.54 (m, 2 H, CH2CN), 3.37–3.54 (m, 1 H, CHCN), 3.80 (s, 3 H,
CH3O), 4.53 (d, 3J = 4.9 Hz, 1 H, CHO).
3
1H NMR (300 MHz, CDCl3): d = 0.88 (t, J = 6.6 Hz, 3 H, CH3),
13C NMR (50 MHz, CDCl3): d = 14.0, 17.1 (2 CH3), 22.4, 24.7,
25.1, 28.9, 31.3 (all CH2), 44.3, 52.9, 77.6 (CHO, CH3O and
CHCN), 117.7 (C=N), 169.6 (C=O).
1.19–1.95 (m, 13 H, CH and 6 CH2), 2.00–2.27 (m, 2 H, CHAHBCN
and CH), 2.36–2.54 (m, 1 H, CHAHBCN), 3.56–3.73 (m, 1 H,
CHCN), 4.90–5.08 (m, 1 H, CHO).
Anal. Calcd for C12H21NO4: C, 59.24; H, 8.70; N, 5.76. Found: C,
59.30; H, 8.52; N, 5.73.
13C NMR (75 MHz, CDCl3): d = 14.0 (CH3), 22.5, 23.6, 25.2, 25.5,
29.1, 30.6, 31.5 (7 CH2), 34.8 (CH2CN), 50.0 (CHCN), 79.6 (CHO),
118.4 (C=N).
Acknowledgment
Anal. Calcd for C12H21NO2: C, 68.21; H, 10.02; N, 6.63. Found: C,
68.26; H, 10.13; N, 6.74.
This work was supported by the Russian Foundation for Basic Re-
search (project 05-03-32733).
3-Benzyl-1-oxa-2-azabicyclo[3.3.04,8]oct-2,3-ene N-Oxide (2f)
Chromatography: hexanes–EtOAc (5:1 to 1:1); Rf 0.38 (hexanes–
EtOAc, 1:1).
References
1H NMR (300 MHz, CDCl3): d = 1.30–1.73 (m, 5 H) and 1.80–2.01
(m, 1 H) (CH2CH2CH2), 3.33–3.51 (m, 2 H, CHCN and CHAHBPh),
3.65 (d, 2J = 15.4 Hz, 1 H, CHAHBPh), 4.74–4.85 (m, 1 H, CHO),
7.05–7.25 (m, 5 H, C6H5).
13C NMR (75 MHz, CDCl3): d = 23.0, 29.8, 31.3, 34.2 (3 CH2 and
CHCN), 49.1 (CH2Ph) 79.4 (CHO), 116.8 (C=N), 126.6 (CHarom),
128.2, (CHarom), 128.3 (CHarom), 134.9 (Carom).
(1) (a) Denmark, S. E.; Thorarensen, A. Chem. Rev. 1996, 96,
137. (b) Seebach, D.; Lyapkalo, I. M.; Dahinden, R. Helv.
Chim. Acta 1999, 82, 1829. For recent studies on six-
membered nitronates see: (c) Tishkov, A. A.; Lesiv, A. V.;
Khomutova, Y. A.; Strelenko, Yu. A.; Nesterov, I. D.;
Antipin, M. Yu.; Ioffe, S. L.; Denmark, S. E. J. Org. Chem.
2003, 68, 9477. (d) Smirnov, V. O.; Ioffe, S. L.; Tishkov, A.
A.; Khomutova, Y. A.; Nesterov, I. D.; Antipin, M. Yu.;
Smit, W. A.; Tartakovsky, V. A. J. Org. Chem. 2004, 69,
8485.
Anal. Calcd for C13H15NO2: C, 71.87; H, 6.96; N, 6.45. Found: C,
71.91; H, 6.74; N, 6.28.
(2) (a) Kohler, E. P.; Barrett, G. R. J. Am. Chem. Soc. 1924, 46,
2105. (b) Tartakovsky, V. A.; Gribov, B. G.; Savostianova,
I. A.; Novikov, S. S. Bull. Acad. Sci. USSR, Div. Chem. Sci.
(Engl. Transl.) 1965, 14, 1602. (c) Clagett, M.; Gooch, A.;
Graham, P.; Holy, N.; Mains, B.; Strunk, J. J. Org. Chem.
1976, 41, 4033. (d) Kaji, E.; Zen, S. Chem. Pharm. Bull.
1980, 28, 479. (e) Arai, N.; Narasaka, K. Bull. Chem. Soc.
Jpn. 1997, 70, 2525. (f) Scardovi, N.; Casalini, A.; Peri, F.;
Righi, P. Org. Lett. 2002, 4, 965. (g) Kanemasa, S.;
Yoshimiya, T.; Wada, E. Tetrahedron Lett. 1998, 39, 8869.
(h) Rosini, G.; Marotta, E.; Righi, P.; Seerden, J.-P. J. Org.
3-Hexyl-1-oxa-2-azatricyclo[3.3.15,8.04,9]dec-2,3-ene N-Oxide
(2g)
Chromatography: hexanes–EtOAc (10:1 to 1:1); Rf 0.50 (hexanes–
EtOAc, 1:1).
3
1H NMR (300 MHz, CDCl3): d = 0.88 (t, J = 6.6 Hz, 3 H, CH3),
1.03–1.81 (m, 14 H, 7 CH2), 2.11–2.29 (m, 1 H, CHAHBCN), 2.33–
2.47 (m, 2 H) and 2.48–2.60 (m, 1 H, CHAHBCN and 2 CH), 3.10
(d, 3J = 8.1 Hz, 1 H, CHCN), 4.42 (d, 3J = 8.1 Hz, 1 H, CHO).
Synthesis 2006, No. 13, 2265–2270 © Thieme Stuttgart · New York